DexCom (DXCM) Revenue — Quarter Ended Dec 31, 2024
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The sequential growth was more pronounced than the year-over-year improvement.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The sequential growth was more pronounced than the year-over-year improvement.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
+12.0%
Change from the immediately preceding quarter.
Year-over-year
+7.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $921M | +24.2% |
| Jun 30, 2024 | $1B | +15.3% |
| Sep 30, 2024 | $994.2M | +2.0% |
| Dec 31, 2024 | $1.1B | +7.6% |
Revenue performance
The reported revenue rose from the prior quarter, building on a trend of sequential gains throughout the fiscal year. The year-over-year comparison also showed an expansion in revenue.
Quarterly comparison
Compared with the preceding quarter, revenue increased, reflecting a higher absolute level. Versus the same quarter a year ago, revenue also grew, though at a slower pace than the sequential change.
What to watch
The company's ability to scale operations and expand internationally may influence future revenue trends.